Association for Molecular Pathology v. Myriad Genetics

Update: 2013-04-15

Description

A case in which the Court held that naturally occurring genes cannot be patented, but a creation of a new product in a lab could be patented.

Comments

In Channel

Metrish v. Lancaster

2013-04-2458:35

University of Texas Southwestern Medical Center v. Nassar

2013-04-2401:01:52

Sekhar v. United States

2013-04-2358:59

Tarrant Regional Water District v. Herrmann

2013-04-2358:15

Hillman v. Maretta

2013-04-2255:17

Agency for International Development v. Alliance for Open Society International

2013-04-2258:51

United States v. Kebodeaux

2013-04-1758:56

Salinas v. Texas

2013-04-1701:01:05

American Trucking Associations v. City of Los Angeles

2013-04-1658:58

Adoptive Couple v. Baby Girl

2013-04-1601:02:39

United States v. Davila

2013-04-1548:54

Association for Molecular Pathology v. Myriad Genetics

2013-04-1501:07:05

United States v. Windsor

2013-03-2701:55:09

Hollingsworth v. Perry

2013-03-2601:19:58

Oxford Health Plans v. Sutter

2013-03-2501:00:00

FTC v. Actavis Inc.

2013-03-2501:01:00

Dan's City Used Cars v. Pelkey

2013-03-2059:19

Horne v. Department of Agriculture

2013-03-2059:24

Sebelius v. Cloer

2013-03-1958:08

Mutual Pharmaceutical Co. v. Bartlett

2013-03-1901:00:58

00:00

Association for Molecular Pathology v. Myriad Genetics

#box-pro-ellipsis-175925446203684{-webkit-line-clamp:2;}Association for Molecular Pathology v. Myriad Genetics

Association for Molecular Pathology v. Myriad Genetics

Association for Molecular Pathology v. Myriad Genetics